Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse

著录项

• 来源
  《British Journal of Haematology》 |2019年第5期|共4页
• 作者

  Cohen Oliver C.; Counsell Nicholas; Rabin Neil; Popat Rakesh; Owen Roger G.; Popova Bilyana; Schofield Oliver; Clifton-Hadley Laura; Lyons-Lewis Janet; Rawstron Andy; Spence Christopher; de Tute Ruth M.; Hughes Derralynn; Moore Sally; Smith Paul; Yong Kwee L.;

  展开▼
• 作者单位

  Univ Coll London Hosp NHS Fdn Trust Haematol London United Kingdom;

  Canc Res UK &

  UCL Canc Trials Ctr London United Kingdom;

  Univ Coll London Hosp NHS Fdn Trust Haematol London United Kingdom;

  Univ Coll London Hosp NHS Fdn Trust Haematol London United Kingdom;

  Leeds Teaching Hosp NHS Trust Leeds W Yorkshire United Kingdom;

  Canc Res UK &

  UCL Canc Trials Ctr London United Kingdom;

  Canc Res UK &

  UCL Canc Trials Ctr London United Kingdom;

  Canc Res UK &

  UCL Canc Trials Ctr London United Kingdom;

  Univ Coll London Hosp NHS Fdn Trust Haematol London United Kingdom;

  Leeds Teaching Hosp NHS Trust Leeds W Yorkshire United Kingdom;

  Canc Res UK &

  UCL Canc Trials Ctr London United Kingdom;

  Leeds Teaching Hosp NHS Trust Leeds W Yorkshire United Kingdom;

  Royal Free Hosp Dept Haematol London United Kingdom;

  Royal United Hosp Bath Avon United Kingdom;

  Canc Res UK &

  UCL Canc Trials Ctr London United Kingdom;

  Inst Canc Res UCL London United Kingdom;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词

  myeloma; transplantation; bortezomib; consolidation; quality of life;

  机译：骨髓瘤;移植;Bortezomib;合并;生活质量;